These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cardiovascular prevention and cardiac rehabilitation]. de Pablo Zarzosa C; del Río Ligorit A; García Porrero E; Boraita Pérez A; Stachurska A Rev Esp Cardiol; 2008 Feb; 61 Suppl 1():97-108. PubMed ID: 18341939 [TBL] [Abstract][Full Text] [Related]
4. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review. Frisinghelli A; Mafrici A Clin Drug Investig; 2007; 27(9):591-604. PubMed ID: 17705568 [TBL] [Abstract][Full Text] [Related]
5. Update in cardiology: Vascular risk and cardiac rehabilitation. Galve E; Castro A; Cordero A; Dalmau R; Fácila L; García-Romero A; Mazón P; Sanmartín M; Alonso García A; Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):124-30. PubMed ID: 24775386 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive cardiovascular disease risk reduction in a cardiac rehabilitation setting. Gordon NF; Haskell WL Am J Cardiol; 1997 Oct; 80(8B):69H-73H. PubMed ID: 9373003 [TBL] [Abstract][Full Text] [Related]
7. The future: screening and effective intervention. Brunton SA Am J Med; 1998 Jun; 104(6A):54S-59S. PubMed ID: 9684853 [TBL] [Abstract][Full Text] [Related]
8. [Refresher course on epidemiology, prevention and rehabilitation in cardiovascular diseases organized by the Center for Cardiovascular Diseases of the Ospedale Riuniti, at the Ospedale S. Camillo, in Rome, 15-19 December 1969]. Menotti A Cuore Circ; 1969 Jun; 53(3):95-134. PubMed ID: 5401577 [No Abstract] [Full Text] [Related]
9. [ICAROS (Italian survey on CardiAc RehabilitatiOn and Secondary prevention after cardiac revascularization): temporary report of the first prospective, longitudinal registry of the cardiac rehabilitation network GICR/IACPR]. Griffo R; Temporelli PL; Fattirolli F; Ambrosetti M; Tramarin R; Vestri AR; De Feo S; Tavazzi L; Monaldi Arch Chest Dis; 2012 Jun; 78(2):73-8. PubMed ID: 23167148 [TBL] [Abstract][Full Text] [Related]
10. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262 [TBL] [Abstract][Full Text] [Related]
11. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention, second edition, 2004: executive summary. Stone JA; Arthur HM; Can J Cardiol; 2005 Oct; 21 Suppl D():3D-19D. PubMed ID: 16292364 [TBL] [Abstract][Full Text] [Related]
12. Benefits of risk factor modification through cardiac rehabilitation. Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532 [TBL] [Abstract][Full Text] [Related]
13. Guidelines for the prevention and management of cardiovascular complications in HIV-infected patients receiving HAART: The Pavia Consensus Statement. Barbaro G Adv Cardiol; 2003; 40():226-32. PubMed ID: 14533558 [No Abstract] [Full Text] [Related]
14. The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Zarnke KB; McAlister FA; Campbell NR; Levine M; Schiffrin EL; Grover S; McKay DW; Myers MG; Wilson TW; Rabkin SW; Feldman RD; Burgess E; Bolli P; Honos G; Lebel M; Mann K; Abbott C; Tobe S; Petrella R; Touyz RM; Can J Cardiol; 2002 Jun; 18(6):604-24. PubMed ID: 12107419 [TBL] [Abstract][Full Text] [Related]
15. Progress toward prevention of cardiovascular disease: a thirty-year retrospective. Levy RI Mod Concepts Cardiovasc Dis; 1978 Oct; 47(10):103-8. PubMed ID: 692514 [No Abstract] [Full Text] [Related]
16. Advances in the prevention and treatment of cardiovascular disease. Weisfeldt ML; Zieman SJ Health Aff (Millwood); 2007; 26(1):25-37. PubMed ID: 17211011 [TBL] [Abstract][Full Text] [Related]
17. Cardiac Prevention and Rehabilitation "3.0": From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR). Pedretti RFE; Fattirolli F; Griffo R; Ambrosetti M; Angelino E; Brazzo S; Corrà U; Dasseni N; Faggiano P; Favretto G; Febo O; Ferrari M; Giallauria F; Greco C; Iannucci M; La Rovere MT; Mallardo M; Mazza A; Piepoli M; Riccio C; Scalvini S; Tavazzi L; Temporelli PL; Mureddu GF Monaldi Arch Chest Dis; 2018 Oct; 88(3):1004. PubMed ID: 30375810 [TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular prevention: new study, new guidelines. The effort keeping the heart healthy]. Einecke D MMW Fortschr Med; 2004 Sep; 146(38):4-6, 8. PubMed ID: 15532422 [No Abstract] [Full Text] [Related]
19. South American guidelines for cardiovascular disease prevention and rehabilitation. Herdy AH; López-Jiménez F; Terzic CP; Milani M; Stein R; Carvalho T; Serra S; Araujo CG; Zeballos PC; Anchique CV; Burdiat G; González K; González G; Fernández R; Santibáñez C; Rodríguez-Escudero JP; Ilarraza-Lomelí H Arq Bras Cardiol; 2014 Aug; 103(2 Suppl 1):1-31. PubMed ID: 25387466 [No Abstract] [Full Text] [Related]
20. [Guidelines for cardiovascular rehabilitation and secondary prevention in China 2018 simplified edition]. Commitee of Cardiac Rehabilitation and Prevention of Chinese Association of Rehabilitation Medicine Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):802-810. PubMed ID: 30392235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]